Vascular Protection and Decongestion Without Renin–Angiotensin–Aldosterone System Stimulation Mediated by a Novel Dual-Acting Vasopressin V1a/V2 Receptor Antagonist-Reference-Cited by-同舟云学术

Vascular Protection and Decongestion Without Renin–Angiotensin–Aldosterone System Stimulation Mediated by a Novel Dual-Acting Vasopressin V1a/V2 Receptor Antagonist

Published:2019-07 Issue:1 Volume:74 Page:44-52
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:

Author:

Kolkhof Peter,Pook Elisabeth,Pavkovic Mira,Kretschmer Axel,Buchmüller Anja,Tinel Hanna,Delbeck Martina,Mondritzki Thomas,Wasnaire Pierre,Dinh Wilfried,Truebel Hubert,Hüser Jörg,Schmeck Carsten

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference45 articles.

1. Acute heart failure syndromes: current state and framework for future research;Gheorghiade;Circulation.,2005

2. Diuretic treatment in heart failure;Ellison;N Engl J Med.,2017

3. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis;Francis;Ann Intern Med.,1985

4. Prospective randomized amlodipine survival evaluation. Diuretic resistance predicts mortality in patients with advanced heart failure;Neuberg;Am Heart J.,2002

5. Responsiveness to loop diuretics in heart failure;Braunwald;Eur Heart J.,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vasopressin receptor antagonists: a patent summary (2018-2022);Expert Opinion on Therapeutic Patents;2023-05-04

2. Vasopressin: a possible link between hypoxia and hypertension;Exploration of Medicine;2022-10-11

3. Copeptin as a predictive marker of incident heart failure;ESC Heart Failure;2021-05-30

4. New Targets in Heart Failure Drug Therapy;Frontiers in Cardiovascular Medicine;2021-05-05

5. Dual Vasopressin Receptor Antagonism to Improve Congestion in Patients With Acute Heart Failure: Design of the AVANTI Trial;Journal of Cardiac Failure;2021-02